In this episode, we have the privilege of speaking with the incredible Corinne Duluk, a leading expert in breast cancer screening technology. Cori will be discussing the importance of proper breast density assessment and its impact on cancer risk. Get ready to dive deep into the world of screening methods, the shortcomings of current technologies, and the groundbreaking advancements that Delphinus Medical Technologies has made to address these challenges. Tune in as Cori enlightens us on the TriAD approach, the innovative SoftVue technology, and the role of ultrasound tomography in breast imaging. We'll also hear about the vital need for patient advocacy and self-care when it comes to breast health. So-sit back, relax, and prepare to be inspired by yet another remarkable woman on "Wisdom of Women." Importance of breast density as a risk factor Breast density as a greater risk factor than having a family history of breast cancer Limitations of Mammography Difficulty in distinguishing cancer from dense breast tissue on mammogram Development of technology to address imaging challenges for women with dense breasts SoftVue as a technology designed for women to be used in combination with mammography Ultrasound technology without radiation or compression Importance of Breast Density Awareness and Patient Advocacy Importance of asking doctors for supplemental tests Emerging Technologies and Advancements Guest Bio: As a marketing professional with more than 15 years in healthcare, Corinne Duluk is a leader driven to improve health outcomes for all individuals. At a young age, she lost her mother to cancer and wanted to pursue a career that offered comfort and support for families going through their cancer journey. After a few starter positions in corporate America, she found her calling at the Barbara Ann Karmanos Cancer Institute in Detroit. Working in a marketing capacity, Corinne was able to provide information and access to resources for cancer patients, and it was her first step in accomplishing her career goals. While at Karmanos she was introduced to the transformative new breast cancer screening device called SoftVue. It was developed by researchers at Karmanos and offered improved cancer detection for an often-forgotten population, women with dense breasts. Once the technology received its first 510k FDA approval, she followed the researchers to their commercial company, Delphinus Medical Technologies, to help with additional clinical research and the eventual commercialization of SoftVue. Corinne's journey to improve healthcare outcomes is just beginning and her passion for helping others gain access to vital healthcare information will continue to drive her career aspirations. Reach Cori on LinkedIn Delphinus Links: Website Delphinus Medical Technologies LinkedIn YouTube

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related